Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

KING OF PRUSSIA, PA US

1. 20110046137 Pyrazole Derivatives as P2X7 Modulators - compound of formula or a pharmaceutically acceptable salt thereof: STR00001 The pyrazole derivatives of 02-24-2011
2. 20110046110 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS 02-24-2011
3. 20110045442 Methods and Apparatus for Producing Dental Stones Base Plates Used in Making Dentures 02-24-2011
4. 20110040074 PRODUCTION METHODS - methods of reducing the levels of a titratable selectable pressure required 02-17-2011
5. 20110039895 PROLYL HYDROXYLASE INHIBITORS - The invention described herein relates to certain benzimidazol-4-ylcarboxamide derivatives of formula STR00001 which are 02-17-2011
6. 20110039812 N-ALKYLCARBONYL-D-AMINO HYDROXYALKYL ESTER COMPOUNDS AND THEIR USE 02-17-2011
7. 20110034515 INDOLE MODULATORS OF THE ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR 02-10-2011
8. 20110034499 SPIROINDOLINES AS MODULATORS OF CHEMOKINE RECEPTORS 02-10-2011
9. 20110033524 TREATMENT OF TUMORS - The invention provides for innovative improvements in tumour therapy particularly therapies which are conducted using endogenous 02-10-2011
10. 20110028486 INDOLES AS MODULATORS OF NICOTICIC ACETYLCHOLINE RECEPTOR SUBTYPE ALPHA-7 02-03-2011
11. 20110021578 Compounds which Potentiate the AMPA Receptor and Uses Thereof in Medicine 01-27-2011
12. 20110020770 DENTAL SPLINTS AND METHOD FOR USING THE SAME 01-27-2011
13. 20110020345 DRUG FUSIONS AND CONJUGATES - drug fusions that have improved serum half lives 01-27-2011
14. 20110020339 METHODS OF TREATMENT - generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production 01-27-2011
15. 20110020328 ANTIBODY FORMULATIONS - This invention relates to a shear and temperature stable antibody formulations that are more stable than compared to a standard 01-27-2011
16. 20110020315 TREATMENT OF INFLAMMATORY ILLNESSES WITH ACE2 01-27-2011
17. 20110015390 PROCESS - The present invention generally relates to a novel process for preparing vitronectin receptor antagonist compounds having a benzodiazepinyl 01-20-2011
18. 20110014182 ANTIGEN BINDING PROTEINS 01-20-2011
19. 20110009440 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS 01-13-2011
20. 20110008747 Method and Apparatus for Electronically Modeling and Manufacturing Dentures 01-13-2011
21. 20110008345 ANTIGEN-BINDING CONSTRUCTS - comprising a protein scaffold which are linked to one or more epitope-binding domains wherein the antigen-binding construct 01-13-2011
22. 20110002953 USE OF IMMIDAZOQUINOLINAMINES AS ADJUVANTS IN DNA VACCINATION 01-06-2011
23. 20110000483 EXTERNAL NASAL DILATOR - nasal dilator with improved functionality by virtue of a resilient element comprised of at least three resilient bands 01-06-2011
24. 20100332253 Systems and Methods for Providing Customized Dentures 12-30-2010
25. 20100330535 Chemo-mechanical Polishing of Dentures - This disclosure relates to a composition and method for cleaning and polishing dentures during denture 12-30-2010
26. 20100329996 Novel Combination of Therapeutic Agents - Novel combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist and/or a 12-30-2010
27. 20100324076 Novel sEH Inhibitors and their Use - The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH 12-23-2010
28. 20100323329 Apparatus and Method for Manufacturing Customized Dentures 12-23-2010
29. 20100322984 ORAL CARE COMPOSITION FOR COMBATING DENTINE HYPERSENSITIVITY 12-23-2010
30. 20100318228 Method and Apparatus for Predicting Properties of Granulated Materials and Dosage Forms made Therefrom 12-16-2010
31. 20100317704 SPIRO-CONDENSED IMIDAZOLONE DERIVATIVES INHIBITING THE GLYCINE TRANSPORTER 12-16-2010
32. 20100317672 Monomaleate Monohydrate Salt of a 5HT1A Receptor Antagonist 12-16-2010
33. 20100317663 ANILINOPYRIDINES AS INHIBITORS OF FAK - compound of formula : STR00001 or a pharmaceutically acceptable salt thereof, wherein R 12-16-2010
34. 20100316634 RECOMBINANT IL-5 ANTAGONISTS USEFUL IN TREATMENT OF IL-5 MEDIATED DISORDERS 12-16-2010
35. 20100316624 TREATMENT OF FIBROSES AND LIVER DISORDERS 12-16-2010
36. 20100316579 NOVEL USE OF ALKYL PHOSPHATE ESTERS - The use of an oral care composition comprising certain alkyl phosphates is described for combating dental erosion 12-16-2010
37. 20100311776 Novel sEH Inhibitors and their Use - The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH 12-09-2010
38. 20100311775 Novel sEH Inhibitors and Their Use - The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH 12-09-2010
39. 20100311740 IMIDAZOPYRIDINE DERIVATIVES AS ACID PUMP ANTAGONISTS 12-09-2010
40. 20100311734 Spiro Compounds Useful as Antagonists of the H1 Receptor 12-09-2010
41. 20100305154 Prolyl Hydroxylase Inhibitors - The invention described herein relates to certain quinoline-8-carboxamide derivatives of formula STR00001 which are 12-02-2010
42. 20100305133 Prolyl Hydroxylase Inhibitors - The invention described herein relates to certain quinoxaline-5-carboxamide derivatives of formula STR00001 which are 12-02-2010
43. 20100305107 QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS 12-02-2010
44. 20100303821 IMMUNOGLOBULINS - antigen binding proteins to human IL-13 including anti-IL-13 antibodies and anti-IL-3/anti-IL-4 mAbdAbs 12-02-2010
45. 20100298861 Delayed Action Spring Force Element for Nasal Dilators 11-25-2010
46. 20100298463 DENTURE ADHESIVE COMPOSITION - improved denture adhesive composition 11-25-2010
47. 20100298398 THROMBOPOIETIN RECEPTOR AGONIST (TPORA) KILLS ACUTE HUMAN MYELOID LEUKEMIA CELLS 11-25-2010
48. 20100298387 IL-8 Receptor Antagonists - This invention relates to novel compounds compositions and combinations thereof useful in the treatment of disease states 11-25-2010
49. 20100298373 OXADIAZOLE DERIVATIVES ACTIVE ON SPHINGOSINE-1-PHOSPHATE (SIP) 11-25-2010
50. 20100298324 Prolyl Hydroxylase Inhibitors - The invention described herein relates to certain 4-oxo-2-thioxo-1 2 3 11-25-2010
51. 20100297097 COMPOUNDS - substituted triazole compounds of the formula : STR00001 and salts thereof 11-25-2010
52. 20100297054 1,2,3-TRIAZOLE DERIVATIVES FOR USE AS STEAROYL-COA DESATURASE INHIBITORS 11-25-2010
53. 20100292325 P-MENTHAWE-3-CARBOXYLIC ACID ESTERS TO TREAT AIRWAYS DISEASES 11-18-2010
54. 20100292295 5-OXO-3-PYRROLIDINECARBOXAMIDE DERIVATIVES AS P2X7 MODULATORS 11-18-2010
55. 20100292224 ISOTHIAZOLIDINE 1,1-DIOXIDE AND TETRAHYDRO-2H-1,2-THIAZINE 1,1-DIOXIDE DERIVATIVES AS P2X7 MODULATORS 11-18-2010
56. 20100292092 ANTIBODY FORMULATIONS - This invention relates to a method for high throughput protein formulations 11-18-2010
57. 20100291163 ORAL CARE COMPOSITION COMPRISING NANOPARTICULATE TITANIUM DIOXIDE 11-18-2010
58. 20100291147 RECOMBINANT RSV ANTIGENS - This disclosure provides recombinant respiratory syncytial virus antigens and methods for making and using them 11-18-2010
59. 20100291103 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS 11-18-2010
60. 20100286201 POLYMORPH FORMS OF (S)-2-((4-BENZOFURANYL)CARBONYLAMINOMETHYL)-1-((4-(2-METHYL-5-(4-FLUOROPH- ENYL)THIAZOLYL)CARBONYL)PIPERIDINE 11-11-2010
61. 20100286041 (5Z)-5-(6-QUINOXALINYLMETHYLIDENE)-2-[(2,6-DICHLOROPHENYL)AMINO]-1,3-THIAZ- OL-4(5H)-ONE 11-11-2010
62. 20100285051 VACCINE - component for a HIV vaccine comprising 11-11-2010
63. 20100280071 BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE 11-04-2010
64. 20100280045 NOVEL COMPOUNDS - The invention is directed to certain novel compounds 11-04-2010
65. 20100280029 NOVEL COMPOUNDS - The invention is directed to certain novel compounds 11-04-2010
66. 20100276329 TOPICAL GLYCOPYRROLATE FORMULATIONS - Individually packaged topical formulations comprising about 11-04-2010
67. 20100273827 OXADIAZOLE DERIVATIVES ACTIVE ON SPHINGOSINE-1-PHOSPHATE (S1p) 10-28-2010
68. 20100273771 OXADIAZOLE DERIVATIVES ACTIVE ON SPHINGOSINE-1-PHOSPHATE (SIP) 10-28-2010
69. 20100273770 1, 2, 4 -OXADIAZOLE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASES 10-28-2010
70. 20100273744 COMPOUNDS - amide compounds processes for their preparation pharmaceutical compositions containing these compounds and to their use in the treatment of 10-28-2010
71. 20100272788 VACCINES FOR MALARIA - novel lipoprotein particle methods for preparing and purifying the same 10-28-2010
72. 20100272786 VACCINE - replication deficient simian adenoviral vector C7 encoding a protein comprising CS protein from P 10-28-2010
73. 20100272745 VACCINES FOR MALARIA - component for a malaria vaccine comprising 10-28-2010
74. 20100267759 INHIBITORS OF Akt ACTIVITY - Invented are novel heterocyclic carboxamide compounds the use of such compounds as inhibitors of protein kinase B activity 10-21-2010
75. 20100267730 NOVEL COMPOUNDS - This invention relates to imidazopyridazine substituted piperidine derivatives and their use as pharmaceuticals 10-21-2010
76. 20100267691 COMBINATIONS COMPRISING 3-PHENYLSULFONYL-8-PIPERAZINYL-1YL-QUINOLINE 10-21-2010
77. 20100266616 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS 10-21-2010
78. 20100261767 OXADIAZOLE DERIVATIVES FOR USE AS S1P1 AGONISTS IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS 10-14-2010
79. 20100261743 NOVEL SEH INHIBITORS AND THEIR USE - The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH 10-14-2010
80. 20100260853 COMPOSITIONS FOR PULMONARY DELIVERY - methods of direct pulmonary delivery of polypeptides e 10-14-2010
81. 20100260797 INFLUENZA COMPOSITION - influenza vaccine formulations and accelerating primary vaccination regimes for immunising against influenza disease 10-14-2010
82. 20100260763 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS METHODS FOR 10-14-2010
83. 20100260692 MOUTHWASH COMPOSITION COMPRISING XANTHAN GUM AND SODIUM FLUORIDE 10-14-2010
84. 20100256919 METHODS FOR DETECTING LP-PLA2 ACTIVITY AND INHIBITION OF LP-PLA2 ACTIVITY 10-07-2010
85. 20100256364 PIPERAZINYL-SULFONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF GPR38 RECEPTOR MEDIATED DISEASES 10-07-2010
86. 20100256199 Crystalline form of an Antimalarial Compound 10-07-2010
87. 20100256157 METHOD OF TREATMENT - This invention relates to the use of a sulfonamide substituted diphenyl urea compound to treat cystic fibrosis 10-07-2010
88. 20100256130 MORPHOLINYL AND PYRROLIDINYL ANALOGS - morpholinyl and pyrrolidinyl analogs pharmaceutical compositions containing them 10-07-2010
89. 20100256124 Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials 10-07-2010
90. 20100254995 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS 10-07-2010
91. 20100254972 METHODS FOR SELECTING PROTEASE RESISTANT POLYPEPTIDES 10-07-2010
92. 20100249137 Novel sEH Inhibitors and Their Use - The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH 09-30-2010
93. 20100247515 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS 09-30-2010
94. 20100242196 TOOTHBRUSH - which comprises a handle comprising at least three longitudinally elongate flexible spines arranged at the apexes of a polygon 09-30-2010
95. 20100240661 AZABICYCLO [3. 1. 0] HEXYL DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS 09-23-2010
96. 20100239666 Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding 09-23-2010
97. 20100234577 METHODS FOR PURIFYING ANTIBODIES USING CERAMIC HYDROXYAPATITE 09-16-2010
98. 20100234386 QUINOXALINE DERIVATIVES AS PI3 KINASE INHIBITORS 09-16-2010
99. 20100233736 DETECTION METHOD AND KIT - method of detection and/or quantification of an antigen linked to a metal salt 09-16-2010
100. 20100233250 VACCINE - or immunogenic composition comprising: an immunogenic SARS coronavirus S polypeptide 09-16-2010
101. 20100233179 BAFF, inhibitors thereof and their use in the modulation of B-cell response 09-16-2010
102. 20100228282 NASAL DEVICES INCLUDING DILATION AND USER COMMUNICATION AND METHODS OF USING SAME 09-09-2010
103. 20100227856 NOVEL COMPOUNDS - This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor 09-09-2010
104. 20100223746 NOVEL DEVICE - toothbrush head with plural tufts of bristles comprising tapered bristles and plural non-tapered bristles 09-09-2010
105. 20100223745 NOVEL DEVICE - toothbrush head with bristles comprising tapered and non-tapered bristles in which the non-tapered bristles extend to two different 09-09-2010
106. 20100221292 INJECTION MOLDING PROCESS FOR THE PREPARATION OF AN ORAL DELIVERY DEVICE FOR THE PHARMACEUTICALLY ACTIVE AGENT 09-02-2010
107. 20100221284 NOVEL VACCINE COMPOSITION - inactivated influenza virus preparation is described which comprises a haemagglutinin antigen stabilised in the absence of 09-02-2010
108. 20100221260 IMMUNOGLOBULINS - antibodies to NOGO pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis 09-02-2010
109. 20100221194 TOPICAL FOAM COMPOSITION - novel oil in water emulsion aerosol foam composition containing an active agent for the treatment of various chronic and 09-02-2010
110. 20100216860 NOVEL COMPOUNDS - Indazole compounds processes for their preparation intermediates usable in these processes 08-26-2010
111. 20100216837 GLYCINE TRANSPORT INHIBITORS - compounds of formula or salts or solvates thereof their use in the manufacture of medicaments for treating neurological 08-26-2010
112. 20100216813 PYRROLIDINEANILINES - compound represented by the following formula I or a pharmaceutically acceptable salt thereof 08-26-2010
113. 20100216801 THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS 08-26-2010
114. 20100215681 FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS 08-26-2010
115. 20100215661 NICOTINAMIDE DERIVATES USEFUL AS P38 INHIBITORS 08-26-2010
116. 20100215652 NICOTINAMIDE DERIVATES USEFUL AS P38 INHIBITORS 08-26-2010
117. 20100210706 PYRROLIDINONE ANILINES AS PROGESTERONE RECEPTOR MODULATORS 08-19-2010
118. 20100210705 Pyrrole and Isoindole Carboxamide Derivatives as P2X7 Modulators 08-19-2010
119. 20100210687 Compounds which have activity at M1 receptor and their uses in medicine 08-19-2010
120. 20100210677 NOVEL COMPOUND, CORRESPONDING COMPOSITIONS, PREPARATION AND/OR TREATMENT METHODS 08-19-2010
121. 20100210667 IMIDAZO [1, 2-C] PYRIMIDIN-2-YLMETHYLPIPERIDINES AS OREXIN RECEPTOR ANTAGONISTS 08-19-2010
122. 20100210656 NOVEL sEH INHIBITORS AND THEIR USE - The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH 08-19-2010
123. 20100210655 NOVEL sEH INHIBITORS AND THEIR USE - The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH 08-19-2010
124. 20100210628 NOVEL sEH INHIBITORS AND THEIR USE - The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH 08-19-2010
125. 20100210470 METHODS FOR DETECTING PROTEIN IN PLASMA - comprising contacting said plasma with a protease capable of digesting said protein into at least one 08-19-2010
126. 20100204273 Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors 08-12-2010
127. 20100204272 Compounds which have activity at M1 receptor and their uses in medicine 08-12-2010
128. 20100204242 Piperazine Derivative Having Affinity for the Histamine H3 Receptor 08-12-2010
129. 20100204222 PYRIDOPYRIMIDINE DERIVATIVES AS P13 KINASE INHIBITORS 08-12-2010
130. 20100203227 TEMPERATURE TELEMETRY IN PROCESSING OF MATERIAL 08-12-2010
131. 20100203071 CHIMERIC ANTIGENS - Chimeric respiratory syncytial virus polypeptide antigens are provided 08-12-2010
132. 20100203032 ORLISTAT COMPOSITIONS - pharmaceutical combination or composition containing a lipase inhibitor preferably orlistat and a bile acid sequestrant is 08-12-2010
133. 20100197754 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride 08-05-2010
134. 20100197679 COMPOUNDS - Bicyclic nitrogen containing compounds and their use as antibacterials 08-05-2010
135. 20100196310 METHODS OF TREATING CANCER BY ADMINISTERING HUMAN IL-18 COMBINATIONS 08-05-2010
136. 20100190825 BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE 07-29-2010
137. 20100190764 Novel compounds - This invention relates to novel Spiro cyclopentane derivatives of formula or a pharmaceutically acceptable salt thereof 07-29-2010
138. 20100189741 OIL-IN-WATER EMULSION INFLUENZA VACCINE 07-29-2010
139. 20100189721 ANTIBODY FORMULATIONS - This invention relates to a shear and temperature stable antibody formulations that are more stable than compared to a standard 07-29-2010
140. 20100186780 DENTAL APPLICANCE CLEANING APPARATUS - The present disclosure is an apparatus that includes a housing having a lid pivotally connected to the housing 07-29-2010
141. 20100184996 PROCESS OF AMIDE FORMATION - process for the formation of 2--N-[2-methyl-1-phenyl-2-propyl]-4,6-bis 07-22-2010
142. 20100184836 VACCINE - This invention relates to novel HIV polypeptide and polynucleotide fusions of Gag Pol and Nef which are useful in immunogenic compositions and 07-22-2010
143. 20100184774 METHODS OF TREATMENT - This invention relates to a method of treating a disease state selected from: Alzheimer's disease Down's syndrome 07-22-2010
144. 20100184751 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS 07-22-2010
145. 20100184022 Hybridization Probe Assay and Array - probe suitable for coupling with a particulate support such as a microbead the probe comprising 07-22-2010
146. 20100183709 FORMULATION - therapeutic formulations based on pumpkin products in particular to encapsulated formulations for oral administration 07-22-2010
147. 20100180392 TOOTHBRUSH WITH LONG TAPERED BRISTLES AND SHORT NON-TAPERED BRISTLES 07-22-2010
148. 20100179144 QUINAZOLINE DERIVATIVES AS P13 KINASE INHIBITORS 07-15-2010
149. 20100179143 NAPHTHYRIDINE, DERIVATIVES AS P13 KINASE INHIBITORS 07-15-2010
150. 20100179139 PYRROLOPYRIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS 07-15-2010
151. 20100179128 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS 07-15-2010
152. 20100168171 Piperidinone Carboxamide Derivatives as P2X7 Modulators 07-01-2010
153. 20100168131 NOVEL COMPOUNDS - Disclosed are N-{[-3--3-azabicyclo [4 07-01-2010
154. 20100168122 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS 07-01-2010
155. 20100168100 QUINOLINE DERIVATIVES AS P13 KINASE INHIBITORS 07-01-2010
156. 20100160644 NOVEL PROCESSES OF MAKING HYDROXY-1-AZO-DERIVATIVES AS TPO MIMETICS 06-24-2010
157. 20100160354 NOVEL COMPOUNDS - therapeutically active xanthine derivative compounds of Formula : STR00001 corresponding processes for manufacture of said derivatives 06-24-2010
158. 20100160345 NOVEL COMPOUNDS - This invention relates to imidazopyrazine substituted piperidine derivatives and their use as pharmaceuticals 06-24-2010
159. 20100160344 NOVEL COMPOUNDS - This invention relates to imidazopyrimidine substituted piperidine derivatives and their use as pharmaceuticals 06-24-2010
160. 20100160336 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors 06-24-2010
161. 20100160209 Composition and Method for Increasing Cell Permeability of a Compound 06-24-2010
162. 20100152235 OXADIAZOLE DERIVATIVES ACTIVE ON SPHINGOSINE-1-PHOSPHATE (S1P) 06-17-2010
163. 20100152195 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors 06-17-2010
164. 20100152112 QUINOLINE DERIVATIVES AS P13 KINASE INHIBITORS 06-17-2010
165. 20100145040 Benzazepine Derivatives For The Treatment of Neurological Disorders 06-10-2010
166. 20100144829 Novel Receptor Antagonists and Their Methods of Use 06-10-2010
167. 20100144765 5,6-TRIMETHYLENEPYRIMIDIN-4-ONE COMPOUNDS 06-10-2010
168. 20100144760 NOVEL COMPOUNDS - Disclosed are N-{[-3--3-azabicyclo[4 06-10-2010
169. 20100144755 Novel Compounds - Novel substituted 2 4 8-trisubstituted 8H-pyrido[2 06-10-2010
170. 20100144727 Oxazolidine and Morpholine Carboxamide Derivatives as P2X7 Modulators 06-10-2010
171. 20100144016 APPARATUS FOR THE DISRUPTION OF ANIMAL CELLS 06-10-2010
172. 20100143501 SOLID COMPOSITION COMPRISING A CLAY SUCH AS KAOLIN 06-10-2010
173. 20100143371 INTRABODIES - single domain intrabody that binds to an intracellular protein or to an intracellular domain of an intracellular protein, such as Etk 06-10-2010
174. 20100137428 OXYGEN CONTAINING HETEROCYCLES AS GLYCINE TRANSPORTER INHIBITING COMPOUNDS 06-03-2010
175. 20100137353 TRICYCLIC COMPOUNDS AS ANTIBACTERIALS - Tricyclic nitrogen containing compounds and their use as antibacterials 06-03-2010
176. 20100137338 INHIBITORS OF Akt ACTIVITY - Invented are novel pyrazole compounds the use of such compounds as inhibitors of protein kinase B activity and in the 06-03-2010
177. 20100137282 TRICYCLIC NITROGEN CONTAINING COMPOUNDS AS ANTIBACTERIAL AGENTS 06-03-2010
178. 20100137276 COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE 06-03-2010
179. 20100130468 INDOLE CARBOXAMIDES AS IKK2 INHIBITORS - The invention is directed to novel indole carboxamide derivatives 05-27-2010
180. 20100129352 NOVEL PHARMACEUTICAL COMPOSITION - Disclosed are novel pharmaceutical compositions containing 3'-[-[1--1 5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-- 05-27-2010
181. 20100126287 PHARMACEUTICAL ANALYSIS APPARATUS AND METHOD 05-27-2010
182. 20100120669 THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE 05-13-2010
183. 20100119597 MULTI-COMPONENT PHARMACEUTICAL DOSAGE FORM 05-13-2010
184. 20100113545 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS 05-06-2010
185. 20100113475 PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK 05-06-2010
186. 20100113444 PROLYL HYDROXYLASE INHIBITORS - The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula 05-06-2010
187. 20100111945 NOVEL USES - generally to the use of human IL-18 combinations in the treatment of cancers 05-06-2010
188. 20100105713 GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders 04-29-2010
189. 20100105652 PURINES AS CYSTEINE PROTEASE INHIBITORS - Substituted heteroaryl nitrile salt of Formula I STR00001 processes for their preparation pharmaceutical 04-29-2010
190. 20100105042 NOVEL METHODS - methods for site-specifically integrating at least one first nucleic acid into a genome of at least one cell 04-29-2010
191. 20100099690 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS 04-22-2010
192. 20100099631 Novel Use - the use of the combined oral administration of caffeine with carbohydrate for increasing the rate of muscle glycogen resynthesis after 04-22-2010
193. 20100093766 NOVEL COMPOUNDS - Novel substituted 1 5 7-trisubstituted-3 04-15-2010
194. 20100093765 NOVEL COMPOUNDS - Novel substituted 1 5 7-trisubstituted-3 04-15-2010
195. 20100087424 TRICYCLIC NITROGEN CONTAINING HETEROCYCLES AS ANTIBACTERIAL AGENTS 04-08-2010
196. 20100086554 METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES 04-08-2010
197. 20100086547 METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES 04-08-2010
198. 20100086499 TOOTH WHITENING COMPOSITION - effective tooth whitening composition comprising a chlorine dioxide precursor 04-08-2010
199. 20100081805 Preparation of a Quinolinyloxydiphenylcyclopropanedicarboxamide 04-01-2010
200. 20100081792 Ligand - dual-specific ligand comprising a first and second single variable domain 04-01-2010
201. 20100081650 Antimicrobial Compounds - Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of 04-01-2010
202. 20100080897 Continuous Coating of Pellets - continuous dosage form coating apparatus uses vibrational impulses to maintain a dosage forms in a fluid state to expose 04-01-2010
203. 20100076017 SITAMAQUINE TOSYLATE FOR THE TREATMENT OF LEISHMANIASIS 03-25-2010
204. 20100075982 Pyridinone Derivative For The Treatment of Premature Ejaculation 03-25-2010
205. 20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators 03-25-2010
206. 20100075928 CANCER TREATMENT METHOD - Invented is a method of treating cancer and pre-cancerous syndromes in a mammal including a human 03-25-2010
207. 20100074947 Pharmaceutical Formulations - novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection moulding of single or 03-25-2010
208. 20100069416 Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors 03-18-2010
209. 20100069409 "NOVEL COMPOUNDS" - Novel substituted 2 4 8-trisubstituted-8H-pyrido[2 03-18-2010
210. 20100069391 Novel sEH Inhibitors and Their Use - The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH 03-18-2010
211. 20100068246 Process for Providing a Quantity of a Particulate Material, Product and Apparatus 03-18-2010
212. 20100068166 ORAL COMPOSITION COMPRISING DIMETHICONE COPOLYOL 03-18-2010
213. 20100063097 Azabicyclo [3.1.0] Hexane Derivatives as Modulators of Dopamine D3 Receptors 03-11-2010
214. 20100063078 SPIROCOMPOUNDS USEFUL AS MODULATORS FOR DOPAMINE D3 RECEPTORS 03-11-2010
215. 20100063004 TOPICAL PHARMACEUTICAL COMPOSITION - This invention relates to a novel topical pharmaceutical composition 03-11-2010
216. 20100056760 SIALOADHESIN FACTOR-2 ANTIBODIES - Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2 03-04-2010
217. 20100056595 Pyrazole Derivatives as P2X7 Modulators - compound of formula or a pharmaceutically acceptable salt thereof: STR00001 wherein R 03-04-2010
218. 20100056523 INHIBITORS OF AKT ACTIVITY - Invented are novel 1H-imidazo[4 5-c]pyridin-2-yl compounds the use of such compounds as inhibitors of protein kinase B 03-04-2010
219. 20100056502 COMPOUNDS - Tricyclic nitrogen containing compounds and their use as antibacterials 03-04-2010
220. 20100055166 NOVEL METHOD AND COMPOSITIONS - inter alia a method of raising an immune response against a pathogen which comprises administering one or more first 03-04-2010
221. 20100048895 Process for Preparing Heterocyclic Derivatives 02-25-2010
222. 20100048656 GLYT1 TRANSPORTER INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS 02-25-2010
223. 20100048617 COMPOUNDS - substituted 3-Aminopyrazole compounds of formula STR00001 and pharmaceutically acceptable salts thereof 02-25-2010
224. 20100048544 PYRROLO (3, 2, 1-IJ) QUINOLINE-4-ONE-DERIVATIVES FOR TREATING TUBERCULOSIS 02-25-2010
225. 20100047348 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) 02-25-2010
226. 20100047347 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) 02-25-2010
227. 20100047346 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) 02-25-2010
228. 20100047243 NOVEL ANTIBODIES AGAINST IGF-IR - antibodies or antigen binding fragments thereof which specifically binds to IGF-1R, specifically hIGF-1R 02-25-2010
229. 20100047237 PREVENTION OF AGGREGATION OF IMMUNOGLOBULIN LIGHT OR HEAVY CHAINS 02-25-2010
230. 20100047191 NOVEL USE - The use of an oral care composition comprising particulate zinc oxide optionally in the presence of a source of fluoride ions is described 02-25-2010
231. 20100047171 Fusion Proteins That Contain Natural Junctions 02-25-2010
232. 20100041757 N-ARYL-HYDROXYALKYLIDENE-CARBOXAMIDE COMPOUNDS AND THEIR USE 02-18-2010
233. 20100041726 INHIBITORS OF Akt ACTIVITY - Invented are novel heterocyclic carboxamide compounds the use of such compounds as inhibitors of protein kinase B activity 02-18-2010
234. 20100041696 Compounds - substituted 4-Aminopyrazole compounds of the formula : STR00001 and pharmaceutically acceptable salts thereof 02-18-2010
235. 20100041672 USE OF QUINOLINE DERIVATIVES IN THE TREATMENT OF PAIN AND IRRITABLE BOWEL SYNDROME 02-18-2010
236. 20100041590 Compounds - substituted 3-Aminopyrazole compounds of formula STR00001 and pharmaceutically acceptable salts thereof 02-18-2010
237. 20100040712 THROAT SPRAY - orally administered composition for relieving or eliminating snoring is described 02-18-2010
238. 20100040684 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) 02-18-2010
239. 20100040683 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) 02-18-2010
240. 20100040679 Compositions for Reducing Nicotine Withdrawal Symptoms and/or Tobacco Usage 02-18-2010
241. 20100040616 TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASE 02-18-2010
242. 20100040562 NOVEL COMPOSITION - post-foaming dentifrice composition having a viscosity of at least 80 000 mPas comprising a combination of a first thickening agent 02-18-2010
243. 20100037713 Pharmaceutical Analysis Apparatus and Method 02-18-2010
244. 20100035917 PYRROLO[2,3-B]PYRIDIN-4-YL-BENZENESULFONAMIDE COMPOUNDS AS 1KK2 INHIBITORS 02-11-2010
245. 20100035914 AZABICYCLIC COMPOUNDS AS INHIBITORS OF MONOAMINES REUPTAKE 02-11-2010
246. 20100029782 Calcilytic Compounds - Novel calcilytic compounds of Formula , pharmaceutical compositions, methods of synthesis, and methods of using them are provided 02-04-2010
247. 20100029740 AZABICYCLIC COMPOUNDS AS SEROTONIN, DOPAMINE AND NOREPINEPHRINE RE-UPTAKE INHIBITORS 02-04-2010
248. 20100029729 COMPOUNDS - novel oxadiazole derivatives having pharmacological activity processes for their preparation 02-04-2010
249. 20100029700 1-(2-ARYL-2-OXOETHYL)-3-PHENYL-1, 4-DIAZASPIRO [4.5]DEC-3-EN-2-ONE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORTER INHIBITORS 02-04-2010
250. 20100029699 MATRIX METALLOPROTEINASE INHIBITORS - compounds of Formula : STR00001 pharmaceutically acceptable salts thereof 02-04-2010
251. 20100022486 COMPOUNDS - substituted 3-Aminopyrazole compounds of formula : STR00001 and pharmaceutically acceptable salts thereof 01-28-2010
252. 20100021473 Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor 01-28-2010
253. 20100018533 Novel Device - face mask comprising a filter material being a fibrous substrate especially non-woven polypropylene or polyester 01-28-2010
254. 20100017989 NOVEL DEVICE - toothbrush head having a bristle carrier and bristles held in bristle holders the bristle holders being connected to the bristle carrier 01-28-2010
255. 20100016399 GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders 01-21-2010
256. 20100016377 Use of a p38 Kinase Inhibitor for Treating Psychiatric Disorders 01-21-2010
257. 20100016374 Compounds Which Inhibit the Glycine Transporter and Uses Thereof 01-21-2010
258. 20100016318 ANTHRANILAMIDE INHIBITORS OF AURORA KINASE 01-21-2010
259. 20100016287 COMPOUNDS HAVING AFFINITY FOR DOPAMINE D3 RECEPTOR AND USES THEREOF" 01-21-2010
260. 20100010053 COMPOUNDS - novel oxadiazole derivatives having pharmacological activity processes for their preparation 01-14-2010
261. 20100010026 STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS 01-14-2010
262. 20100010021 NOVEL COMPOUNDS - therapeutically active xanthine derivative compounds of Formula : STR00001 corresponding processes for manufacture of said derivatives 01-14-2010
263. 20100009956 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS 01-14-2010
264. 20100009910 METHODS FOR ADMINISTERING LONG-LASTING HYPOGLYCEMIC AGENTS 01-14-2010
265. 20100004452 5-QUINOLINONE DERIVATIVES AS 5HT1A RECEPTOR MODULATORS FOR TREATING SEXUAL DYSFUNCTION, COGNITION IMPAIRMENT, PSYCHOTIC DISORDERS, ANXIETY, DEPRESSION, ETC. 01-07-2010
266. 20100004302 Methods for Treating Degenerative Diseases/Injuries 01-07-2010
267. 20100004230 AZATRICYCLIC COMPOUNDS AND THEIR USE - Tricyclic nitrogen containing compounds and their use as antibacterials 01-07-2010
268. 20090326027 N-Phenyl-2-0X0-1,4-Diazaspiro [4.5] Dec-3-EN-1-YL Acetamide Derivatives And Their Use As Glycine Transporter Inhibitors 12-31-2009
269. 20090326011 AZAB I CYCLO [3 . 1 . 0] HEXANE DERIVATIVES AS DOPAMIN D3 RECEPTOR MODULATORS 12-31-2009
270. 20090326003 PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORS 12-31-2009
271. 20090325993 GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders 12-31-2009
272. 20090325952 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS 12-31-2009
273. 20090320849 Anti-Viral Face Mask and Filter Material 12-31-2009
274. 20090318539 Process for Preparing a Particle Comprising a Biological Molecule and a Carrier Polymer 12-24-2009
275. 20090318494 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS 12-24-2009
276. 20090318447 N-[6-(4-MORPHOLINYL)-3-PYRIDINYL]-2-(TETRAHYDRO-2H-PYRAN-4-YL)-N-[(1--4-PI- PERIDINYL) METHYL] ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS GLYT1 TRANSPORT INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS SUCH AS SCHIZOPHRENIA 12-24-2009
277. 20090318424 NOVEL COMPOUNDS - Novel substituted 1 5 7-trisubstituted-3 12-24-2009
278. 20090313779 TOOTHBRUSH - with a cleaning zone with bristles and with a deformable element by which the cleaning zone can be adapted to the shape of the tooth 12-24-2009
279. 20090312546 QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS 12-17-2009
280. 20090306113 PHARMACEUTICAL FORMULATION - enteric polymer coated tablet formulations for oral administration which comprise a phospholipase A2 enzyme Lipoprotein 12-10-2009
281. 20090306089 COMPOUNDS - of Formula or pharmaceutically acceptable salts or N-oxides thereof: STR00001 pharmaceutical compositions comprising them 12-10-2009
282. 20090306074 THIAZOLIDINEDIONE DERIVATIVES AS P13 KINASE INHIBITORS 12-10-2009
283. 20090306066 PEPTIDE DEFORMYLASE INHIBITORS - certain {2--3-[2-hydrazino]-3-oxopropyl}hydroxyfor- mamide derivatives 12-10-2009
284. 20090304634 Novel Combinations - Invented is a method of treating viral diseases particularly hepatitis C in a human 12-10-2009
285. 20090298841 QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS 12-03-2009
286. 20090298810 IL-8 Receptor Antagonists - This invention relates to novel compounds and compositions thereof useful in the treatment of disease states mediated by the 12-03-2009
287. 20090298179 Methods For Treating Degenerative Diseases/Injuries 12-03-2009
288. 20090291995 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-Y- LIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE) 11-26-2009
289. 20090291987 NOVEL POLYMORPH OF (5-AMINO-6-METHOXY-3-PYRIDINCARBONYL) CARBAMIC ACID 2-(S)-HYDROXYMUTILIN 14-ESTER 11-26-2009
290. 20090291442 HSPA1A AS A MARKER FOR SENSITIVITY TO KSP INHIBITORS 11-26-2009
291. 20090287332 SYSTEM AND METHOD FOR MANUFACTURING FULL AND PARTIAL DENTURES 11-19-2009
292. 20090286828 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES 11-19-2009
293. 20090281135 3-AZABICYCLO [4. 1. 0] HEPTANE DERIVATIVES FOR THE TREATMENT OF DEPRESSION 11-12-2009
294. 20090281110 Method of Treatment - This invention relates to the use of sulfonamide substituted diphenyl urea compounds to treat endometriosis 11-12-2009
295. 20090280192 METHOD FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE 11-12-2009
296. 20090275604 M3 Muscarinic Acetylcholine Receptor Antagonists 11-05-2009
297. 20090275571 MORPHOLINYL AND PYRROLIDINYL ANALOGS - morpholinyl and pyrrolidinyl analogs pharmaceutical compositions containing them 11-05-2009
298. 20090274726 SYNTHETIC GENE - s processes for designing said synthetic genes and their uses in gene therapy and improved DNA vaccination 11-05-2009
299. 20090274693 Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor 11-05-2009
300. 20090270510 GLYCINE TRANSPORT INHIBITORS - compounds of formula or salts or solvates thereof their use in the manufacture of medicaments for treating neurological 10-29-2009
301. 20090270456 Novel chemical compounds - This invention relates to newly identified compounds for inhibiting hYAK3 and/or CK2 proteins and methods for treating 10-29-2009
302. 20090270374 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES 10-29-2009
303. 20090264499 Cathepsin C Inhibitors - compound of formula or STR00001 and their use in treating inflammatory diseases such as COPD 10-22-2009
304. 20090264498 Cathepsin C Inhibitors - This invention relates to compounds of formula STR00001 which are useful for treating chronic obstructive pulmonary disease, 10-22-2009
305. 20090264431 NOVEL CATHEPSIN C INHIBITORS AND THEIR USE 10-22-2009
306. 20090263470 Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant 10-22-2009
307. 20090263422 INFLUENZA VACCINE - monovalent influenza vaccine formulations and vaccination regimes for immunising against influenza disease 10-22-2009
308. 20090259026 Ligand - dual-specific ligand comprising a first immunoglobulin variable domain having a first binding specificity and a complementary or 10-15-2009
309. 20090258858 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS 10-15-2009
310. 20090257961 DENTURE CARE COMPOSITION - This invention relates to a new denture care composition and method of use 10-15-2009
311. 20090253908 NOVEL M3 MUSCARINIC ACETYLCHOINE RECEPTOR ANTAGONISTS 10-08-2009
312. 20090253700 N-'4-4(4-MORPHOLINYL) PHENYL!- '(4-PIPERIDINYL) METHYL! CARBOXAMIDE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORTER INHIBITORS 10-08-2009
313. 20090252759 IMMUNOGENIC COMPOSITION - The present application relates to an immunogenic composition comprising at least 2 conjugates of N 10-08-2009
314. 20090247541 Novel compounds - Compounds of formula STR00001 wherein R 10-01-2009
315. 20090239927 Statin and Omega-3 Fatty Acids For Lipid Therapy 09-24-2009
316. 20090239897 NOVEL COMPOUNDS - Novel substituted 1 5 7-trisubstituted-1 09-24-2009
317. 20090239866 PEPTIDE DEFORMYLASE INHIBITORS - Novel PDF inhibitors and novel methods for their use are provided 09-24-2009
318. 20090239846 Novel Compounds - Novel substituted 1 5 7-trisubstituted-3 09-24-2009
319. 20090239845 PYRAZOLE COMPOUNDS AS PROSTAGLANDIN RECEPTORS LIGANDS 09-24-2009
320. 20090233333 Methods for preventing gluconoylation of proteins 09-17-2009
321. 20090232847 Immunogenic compositions - methods and compositions useful in the treatment and prevention of Hepatitis C virus infections and the symptoms and diseases 09-17-2009
322. 20090221643 4-PHENYL-3-(2-PROPYLSULFONYLAMINO) TETRAHYDROFURAN DERIVATIVES WHICH POTENTIATE GLUTAMATE RECEPTORS AND ARE USEFUL IN THE TREATMENT OF SCHIZOPHRENIA 09-03-2009
323. 20090221618 AZABICYCLO (3, 1, 0) HEXAN DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS 09-03-2009
324. 20090221593 TRIAZOLE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS 09-03-2009
325. 20090221577 COMPOUNDS HAVING MORPHOLINYL AND PIPERIDINYL GROUPS FOR USE AS GLYT1 INHIBITORS 09-03-2009
326. 20090217677 FREEZING AND STORAGE CONTAINER FOR BIOPHARMACEUTICAL DRUG PRODUCTS 09-03-2009
327. 20090217472 TOOTHBRUSH - grip handle made of a plastics material including one or plural voids having an opening at the surface of the grip handle and at least 09-03-2009
328. 20090215818 THIOZOLIDINEDIONE DERIVATIVES AS PI3 KINASE INHIBITORS 08-27-2009
329. 20090214534 Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY 08-27-2009
330. 20090213582 Illuminated Display - display device that can be mounted to a surface, such as a car or refrigerator using magnetic attraction 08-27-2009
331. 20090211928 NOVEL DEVICE - card package of rectangular cross section suitable for a toothpaste tube which has a recessed region 08-27-2009
332. 20090209607 INHIBITORS OF AKT ACTIVITY - Invented are novel heterocyclic carboxamide compounds the use of such compounds as inhibitors of protein kinase B activity 08-20-2009
333. 20090209561 Xanthine Derivatives with HM74A Receptor Activity 08-20-2009
334. 20090209472 AMIDE AND PEPTIDE DERIVATIVES OF DIALKYLENETRIAMINES AND THEIR USE AS TRANSFECTION AGENTS 08-20-2009
335. 20090208515 VACCINE COMPOSITION - virus vectors comprising oligonucleotides encoding HIV polypeptides 08-20-2009
336. 20090208444 Novel Formulation - sanitising formulation comprising a solution of an acidic polymer and an anionic surfactant in a liquid vehicle 08-20-2009
337. 20090207074 Near simultaneous dissemination of global data from many sources to many receivers 08-20-2009
338. 20090203732 Thiazolones for Use as P13 Kinase Inhibitors 08-13-2009
339. 20090203692 NOVEL CHEMICAL COMPOUNDS - This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases 08-13-2009
340. 20090203677 Dual Pharmacophores - PDE4-Muscarinic Antagonistics 08-13-2009
341. 20090203657 Dual Pharmacophores - PDE4-Muscarinic Antagonistics 08-13-2009
342. 20090203542 SELECTION SYSTEM - The present invention concerns a method for the selection of a virus comprising the steps of: providing a virus encoding and 08-13-2009
343. 20090203144 HIV-GAG CODON-OPTIMISED DNA VACCINES - nucleotide sequence that encodes an HIV-1 gag protein or fragment thereof containing a gag epitope and a second 08-13-2009
344. 20090197928 Novel Receptor Antagonists and Their Methods of Use 08-06-2009
345. 20090197871 Dual Pharmacophores - PDE4-Muscarinic Antagonistics 08-06-2009
346. 20090192294 MAGI POLYNUCLEOTIDES, POLYPEPTIDES, AND ANTIBODIES 07-30-2009
347. 20090192160 COMPOUNDS - of formula STR00001 processes for their preparation pharmaceutical compositions containing them and their use in the treatment of conditions 07-30-2009
348. 20090186867 Substituted Diketopiperazines As Oxytocin Antagonists 07-23-2009
349. 20090186092 SYSTEM AND METHOD FOR MANUFACTURING ORAL OSMOTIC DRUG DELIVERY DEVICES, AND METHODS OF ADMINISTERING SAME 07-23-2009
350. 20090186075 Composition - the use of a composition comprising an antigen recognizing molecule or fragment thereof and a lipid-based carrier for blocking an 07-23-2009
351. 20090182022 Treatment of Fatty Liver - Methods and compositions comprising peroxisomal and/or mitochondrial beta oxidation stimulating agents to reverse or resolve 07-16-2009
352. 20090181052 VACCINE - method for prevention of HPV infection and/or disease the method comprising delivery of a first HPV vaccine comprising an L1 protein or 07-16-2009
353. 20090176973 THROMBOPOIETIN MIMETICS - Invented are non-peptide TPO mimetics 07-09-2009
354. 20090176825 PROLYL HYDROXYLASE INHIBITORS - The invention described herein relates to certain bicyclic heteroaromatic N-substituted glycine derivatives of formula 07-09-2009
355. 20090176746 THROMBOPOIETIN MIMETICS - Invented are non-peptide TPO mimetics 07-09-2009
356. 20090176209 Selection - The present invention to a nucleotide sequence encoding one or more Arc DNA binding domains one or more Arc DNA binding sites and at least 07-09-2009
357. 20090175788 RADIOLABELLED LIGAND FOR THE GLYCINE 1 TRANSPORTER 07-09-2009
358. 20090170955 Fast Release Paracetamol Tablets - pharmaceutical composition such as a swallow tablet or capsule formulation is described comprising paracetamol 07-02-2009
359. 20090170902 COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE 07-02-2009
360. 20090170877 5,6-Trimethylenepyrimidin-4-one compounds 07-02-2009
361. 20090170871 IL-8 Receptor Antagonists - This invention relates to novel compounds and compositions thereof useful in the treatment of disease states mediated by the 07-02-2009
362. 20090170848 THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS 07-02-2009
363. 20090170791 MACROLONES - compound of formula STR00001 or a pharmaceutically acceptable derivative thereof having antimicrobial activity 07-02-2009
364. 20090163589 Calcilytic Compounds - Novel calcilytic compounds and methods of using them are provided 06-25-2009
365. 20090163506 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain 06-25-2009
366. 20090163475 CRYSTALLINE FORM OF BENZAZEPINIUM MALEATE DERIVATIVE 06-25-2009
367. 20090162843 IDENTIFICATION OF HPV16 LINEAGE GROUP - method for identification of an HPV16 lineage group in a sample comprising contacting such nucleic acid 06-25-2009
368. 20090162723 Integrated Single-Chamber Solid Oxide Fuel Cells 06-25-2009
369. 20090162358 ANTIGEN BINDING PROTEINS 06-25-2009
370. 20090159841 Recovery of Optically Active Epoxy Alcohols 06-25-2009
371. 20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof 06-18-2009
372. 20090156597 Novel Compounds - Novel substituted 2 4 8-trisubstituted 8H-pyrido[2 06-18-2009
373. 20090155315 PHARMACEUTICAL PRODUCT - pharmaceutical and pharmaceutical-like product is provided 06-18-2009
374. 20090155309 Novel vaccine - use of a non-live influenza virus antigen preparation particularly a split influenza virus preparation 06-18-2009
375. 20090155283 Noncompetitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1 06-18-2009
376. 20090155203 THROMBOPOIETIN MIMETICS - Invented are non-peptide TPO mimetics 06-18-2009
377. 20090149524 N-(Phenylmethyl)-2-(1H-Pyrazol-4-yl) Acetamide Derivatives as P2X7 Antagonists for the Treatment of Pain, Inflammation and Neurodegeneration 06-11-2009
378. 20090149507 METHOD FOR CUSTOMIZED DISPENSING OF VARIABLE DOSE DRUG COMBINATION PRODUCTS FOR INDIVIDUALIZING OF THERAPIES 06-11-2009
379. 20090149447 Novel M3 Muscarinic Acetylcholine Receptor Antagonists 06-11-2009
380. 20090149401 AMIDE AND PEPTIDE DERIVATIVES OF TETRAALKYLENEPENTAMINES AS TRANSFECTION AGENTS 06-11-2009
381. 20090148905 ANTIGEN-BINDING CONSTRUCTS - comprising a protein scaffold which are linked to one or more epitope-binding domains wherein the antigen-binding construct 06-11-2009
382. 20090148892 NOVEL METHODS - This present invention relates to the use of the B1 domain of Protein G as an epitope tag for over-expression of proteins in mammalian 06-11-2009
383. 20090148518 Pharmaceutical Formulations - novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection moulding of single or 06-11-2009
384. 20090148437 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS 06-11-2009
385. 20090148434 Antibody Compositions and Methods - Provided are concentrated preparations comprising single immunoglobulin variable domain polypeptides that bind 06-11-2009
386. 20090143453 METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES 06-04-2009
387. 20090143372 CHEMICAL COMPOUNDS - The invention is directed to novel indole carboxamide derivatives 06-04-2009
388. 20090142279 NOVEL M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS 06-04-2009
389. 20090137568 Tryclic Nitrogen Containing Compounds and their Use as Antibacterials 05-28-2009
390. 20090137557 Calcilytic Compounds - Novel calcilytic compounds, pharmaceutical compositions, methods of synthesis and methods of using them are provided 05-28-2009
391. 20090137550 Novel Compounds - This invention relates to a novel group of 8-Alkyl/Aryl-4-aryl-2-N--N''-substituted-N'-cyanoguanidino-8H- -pyrido[2 05-28-2009
392. 20090137465 NOVEL USE - generally to the use of PA131 polypeptides and polynucleotides for healing various wounds arising from different causes 05-28-2009
393. 20090136543 VACCINE - immunogenic influenza composition in a dose volume suitable for human use 05-28-2009
394. 20090136541 IMMUNOGENIC COMPOSITION - The present application discloses an immunogenic composition comprising at least 2 different N 05-28-2009
395. 20090131453 BENZYLPIPERAZINE DERIVATIVES AS MOTILIN RECEPTOR ANTAGONISTS 05-21-2009
396. 20090131431 Pyrazolo[3,4-b]pyridine compounds, and their use as a PDE4 inhibitors 05-21-2009
397. 20090130145 VACCINE - attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence 05-21-2009
398. 20090130126 DNA EXPRESSION VECTORS - DNA vectors containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that 05-21-2009
399. 20090130032 DENTAL APPLIANCE CLEANSER - This invention relates to a dental appliance cleanser which is a metastable emulsion comprising about 50-99% w/w of an 05-21-2009
400. 20090125875 METHOD FOR MANUFACTURING A FINAL PRODUCT OF A TARGET SOFTWARE PRODUCT 05-14-2009
401. 20090125324 MEDICAL PRODUCT DISPENSING SYSTEMS AND METHODS 05-14-2009
402. 20090124653 Muscarinic Acetylcholine Receptor Antagonists 05-14-2009
403. 20090124629 3-(1,2,4-TRIAZOL-3YLALKYL) AZABRICLO (3.1.0) HEXANE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS 05-14-2009
404. 20090124619 NOVEL COMPOUNDS - This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor 05-14-2009
405. 20090123496 PURIFICATION OF HBV ANTIGENS FOR USE IN VACCINES 05-14-2009
406. 20090123491 Novel method for preventing or treating M tuberculosis infection 05-14-2009
407. 20090123479 IMMUNOGLOBULINS - antigen binding proteins to human IL-23 pharmaceutical formulations containing them and to the use of such antigen binding proteins in 05-14-2009
408. 20090118313 Novel Compounds - Pyrimidone compounds of formula : STR00001 are inhibitors of the enzyme Lp-PLA 05-07-2009
409. 20090118280 Compounds Which Potentiate AMPA Receptor and Uses Thereof in Medicine 05-07-2009
410. 20090111760 MACROLONE COMPOUNDS - compound of formula STR00001 compositions comprising same processes for their preparation and use of said compounds 04-30-2009
411. 20090105478 NOVEL COMPOUNDS - Novel substituted 2 4 8-trisubstituted-8H-pyrido[2 04-23-2009
412. 20090105259 Acyclic 1,4-Diamines and Uses Thereof - This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel 04-23-2009
413. 20090104231 VACCINE - methods and compositions useful in the treatment and prevention of Hepatitis C virus infections and the symptoms and diseases associated 04-23-2009
414. 20090104229 NOVEL USE - The invention provides the use of 04-23-2009
415. 20090104153 METHOD OF ELICITING IMMUNE RESPONSE - methods of eliciting an immune response by use of a prime-boost schedule for delivering a polynucleotide encoding 04-23-2009
416. 20090093492 IL-8 RECEPTOR ANTAGONISTS - This invention relates to novel compounds of Formula to and compositions thereof useful in the treatment of disease states 04-09-2009
417. 20090093478 N-AROYL CYCLIC AMINES - Disclosed are N-aroyl cyclic amine derivatives having the formula: STR00001 wherein the substituent variables are as defined 04-09-2009
418. 20090093451 IL-8 Receptor Antagonists - This invention relates to novel compounds and compositions thereof useful in the treatment of disease states mediated by the 04-09-2009
419. 20090088374 NOVEL USE - generally to the use of PA126 polypeptides and polynucleotides for healing various wounds arising from different causes 04-02-2009
420. 20090082390 PIPERIDINE COMPOUNDS FOR USE AS OREXIN RECEPTOR ANTAGONIST 03-26-2009
421. 20090082377 Matrix Metalloproteinase Inhibitors - compounds of Formula : STR00001 or pharmaceutically acceptable salts thereof 03-26-2009
422. 20090082357 Prolyl Hydroxylase Inhibitors - The invention described herein relates to certain bicyclic heteroaromatic N-substituted glycine derivatives of formula 03-26-2009
423. 20090082349 THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS 03-26-2009
424. 20090082260 COMBINATION OF AN IMMUNOSUPPRESSANT AND A PPAR GAMMA AGONIST FOR THE TREATMENT OF AN UNDESIRABLE IMMUNE RESPONSE 03-26-2009
425. 20090081253 COMPOSITION - influenza vaccine formulations and vaccination regimes for immunising against various diseases 03-26-2009
426. 20090076783 Digitally optimized fastener assembly and method of making the same 03-19-2009
427. 20090076274 BENZOXAZINONE DERIVATIVES, PREPARATION THEREOF AND USES IN THE TREATMENT OF CNS AND OTHER DISORDERS 03-19-2009
428. 20090076061 MUSCARINIC ACETYCHOLINE RECEPTOR ANTAGONISTS 03-19-2009
429. 20090075822 Method of Altering the Alkaloid Composition in Poppy Plants 03-19-2009
430. 20090074676 Inhibition of p38 MAPK For Treatment Of Obesity 03-19-2009
431. 20090069318 Novel Compounds - Novel substituted 2 4 8-trisubstituted 8H-pyrido[2 03-12-2009
432. 20090062360 Compounds Which Inhibit the Glycine Transporter and Uses Thereof 03-05-2009
433. 20090062265 Pyrrolo-Quinoxalinone Derivatives as Antibacterials 03-05-2009
434. 20090062218 MACROLONE COMPOUNDS - compound of formula STR00001 compositions comprising same processes for their preparation and use of said compounds 03-05-2009
435. 20090054456 BENZYLPIPERAZINE DERIVATIVES AND THEIR MEDICAL USE 02-26-2009
436. 20090054418 Antibacterial Agents - 2H-chromen-2-one derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed 02-26-2009
437. 20090053687 METHOD FOR THE DETECTION OF HPV AND PROBES, PRIMERS AND KITS 02-26-2009
438. 20090053291 FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS 02-26-2009
439. 20090053214 Humanised Anti-MAG Antibody or Functional Fragment Thereof 02-26-2009
440. 20090048444 Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one Derivatives 02-19-2009
441. 20090048442 Novel compounds - Novel substituted pyrimido[4,5-d]pyrimidin-2-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors 02-19-2009
442. 20090048318 METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES 02-19-2009
443. 20090048252 THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS 02-19-2009
444. 20090041802 IMMUNOGENIC COMPOSITION - The present application discloses an immunogenic composition comprising N 02-12-2009
445. 20090038097 TOOTHBRUSH - head in which oral hygiene parts, in particular toothbrush bristles, are set in a flexible pad 02-12-2009
446. 20090036821 Iontophoretic Transdermal Delivery of Nicotine Salts 02-05-2009
447. 20090036682 Quinoline Derivatives and Their Use as 5-HT6 Ligands 02-05-2009
448. 20090036461 Use of Azabicyclo Hexane Derivatives - new use of a compound of formula or a pharmaceutically acceptable salt or solvate salt thereof: STR00001 wherein: 02-05-2009
449. 20090036442 N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS 02-05-2009
450. 20090036433 Heterocyclic Compounds, their Preparation and their Use as Antibacterials 02-05-2009
451. 20090035258 METHODS OF TREATING CANCER BY ADMINISTERING HUMAN IL-18 COMBINATIONS 02-05-2009
452. 20090030062 AZABICYCLO [3.1.0] HEXYLPHENYL DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS 01-29-2009
453. 20090029986 N-AROYL CYCLIC AMINES - Disclosed are N-aroyl cyclic amine derivatives having the formula: STR00001 wherein the substituent variables are as defined 01-29-2009
454. 20090028903 Novel use - influenza vaccine formulations and vaccination regimes for immunising against influenza disease 01-29-2009
455. 20090028828 Rotavirus Vaccine Inducing Heterotypic Cross Protection 01-29-2009
456. 20090023757 PROCESS FOR PREPARING BICYCLIC COMPOUNDS 01-22-2009
457. 20090023742 THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS 01-22-2009
458. 20090023725 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors 01-22-2009
459. 20090022849 Prebiotic Use of Fruits and Fruit Juices in the Promotion of Beneficial Gut Microflora 01-22-2009
460. 20090022814 CANCER TREATMENT METHOD - Invented is a method of treating cancer in a mammal including a human in need thereof which comprises the administration of an 01-22-2009
461. 20090022755 VACCINES AGAINST CHLAMYDIAL INFECTION - compositions comprising proteins or polynucleotides of Chlamydia sp 01-22-2009
462. 20090022670 NOVEL COMPOUNDS - Disclosed are imidazo[1,2-a]pyridin-2-ylmethyl substituted piperidine derivatives of formula STR00001 and their use as pharmaceuticals 01-22-2009
463. 20090019867 Food chiller - food cooling assembly is disclosed 01-22-2009
464. 20090018131 QUINAZOLINE DERIVATIVES AS P13 KINASE INHIBITORS 01-15-2009
465. 20090017020 RECOMBINANT IL-5 ANTAGONISTS USEFUL IN TREATMENT OF IL-5 MEDIATED DISORDERS 01-15-2009
466. 20090013489 NOVEL DEVICE - Toothbrush heads with bristle tufts comprised of longer tapered bristles and shorter non-tapered bristles in respective embodiments 01-15-2009
467. 20090012122 N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS 01-08-2009
468. 20090012083 N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS 01-08-2009
469. 20090012073 N-AROYL CYCLIC AMINES - Disclosed are N-aroyl cyclic amine derivatives having the formula: STR00001 wherein the substituent variables are as defined 01-08-2009
470. 20090012056 Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor 01-08-2009
471. 20090012011 Novel Compounds - This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor 01-08-2009
472. 20090010970 DISSOLVABLE TOOTH WHITENING STRIP - dissolvable strip for whitening teeth 01-08-2009
473. 20090005401 Novel Compounds - This invention relates to a novel group of 8-Alkyl/Aryl-4-aryl-2-N--N''-substituted-N'-cyanoguanidino-8H- -pyrido[2 01-01-2009
474. 20080318990 SPIROINDOLINES AS MODULATORS OF CHEMOKINE RECEPTORS 12-25-2008
475. 20080318947 Inhibitors of Akt Activity - Invented are novel 1H-imidazo[4 5-c]pyridin-2-yl compounds the use of such compounds as inhibitors of protein kinase B 12-25-2008
476. 20080318945 Novel Compounds - This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor 12-25-2008
477. 20080318944 N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS 12-25-2008
478. 20080318933 5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders 12-25-2008
479. 20080317787 Anti-Malaria Vaccine - There is provided inter alia a method for the prophylaxis of productive malaria infection in travelers to endemic regions 12-25-2008
480. 20080317703 Novel Composition for Xerostomia - oral care composition is described for use in the treatment or alleviation of the symptoms of dry mouth comprising 12-25-2008
481. 20080314052 Freezing and Storage Container For Biopharmaceutical Drug Products 12-25-2008
482. 20080312444 Process for Preparing Bicyclic Compounds 12-18-2008
483. 20080312213 7-Pyrazolylbenzazepines Having Affinity For D3 Receptor 12-18-2008
484. 20080312209 Piperazine Heteroaryl Derivatives as Gpr38 Agonists 12-18-2008
485. 20080312167 4'' Amino Linked Macrolides Useful for the Treatment of Microbial Infections 12-18-2008
486. 20080311146 Immunogenic Composition - comprising at least two different isolated staphylococcal polypeptides 12-18-2008
487. 20080306622 Machine and Method for Pharmaceutical and Pharmaceutical-Like Product Assembly 12-11-2008
488. 20080306120 Azaindole inhibitors of aurora kinases - compound represented by Formula : and pharmaceutically acceptable salts 12-11-2008
489. 20080306112 Benzimidazolones Which Have Activity at M1 Receptor 12-11-2008
490. 20080306092 Pyrazolo [1,5-Alpha] Pyrimidinyl Derivatives Useful as Corticotropin-Releasing Factor (Crf) Receptor Antagonists 12-11-2008
491. 20080306083 Biaryl Compounds Useful as Agonists of the Gpr38 Receptor 12-11-2008
492. 20080300239 QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS 12-04-2008
493. 20080294131 Disposable absorbent article and polymer film having odor control and/or skin health agents 11-27-2008
494. 20080293829 Novel Compounds - This invention relates to newly identified ester-linked gemini surfactant compounds, to the use of such compounds and to their 11-27-2008
495. 20080293802 Chemical Compounds - The invention is directed to novel indole carboxamide derivatives 11-27-2008
496. 20080293770 Compounds Which Have Activity at M1 Receptor and Their Uses In Medicine 11-27-2008
497. 20080293720 Pyridinyl Sulfonamide Modulators of Chemokine Receptors 11-27-2008
498. 20080293706 QUINOXALINE DERIVATIVES AS PI3 KINASE INHIBITORS 11-27-2008
499. 20080293656 PROCESSING NUCLEIC ACID - method of processing nucleic acid 11-27-2008
500. 20080293015 Adhesive Liner - denture adhesive liner in the form of an extruded film or sheet 11-27-2008
501. 20080292686 Vaccine - novel intradermal vaccines and novel uses for adjuvants in the preparation of intradermal vaccines 11-27-2008
502. 20080292669 Foamed Substrate and Method for Making Same 11-27-2008
503. 20080287547 Glycine Transport Inhibitors - compounds of formula or to salts or solvates thereof their use in the manufacture of medicaments for treating 11-20-2008
504. 20080287487 Muscarinic Acetylcholine Receptor Antagonists 11-20-2008
505. 20080287461 Pyridinone Derivatives Against Malaria - 4-pyridone derivatives of Formula and pharmaceutically acceptable derivatives thereof processes for their 11-20-2008
506. 20080287225 Baseball batting instruction system and method 11-20-2008
507. 20080286865 Methods for the Preservation of Platelet Efficacy During Storage 11-20-2008
508. 20080280919 QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS 11-13-2008
509. 20080280892 Compounds - Tricyclic nitrogen containing compounds and their use as antibacterials 11-13-2008
510. 20080279890 VIRAL ANTIGENS - vaccine composition comprising VLPs containing L1 proteins or functional L1 protein derivatives from HPV 16 11-13-2008
511. 20080279852 Methods of treatment with glycosylated antibodies 11-13-2008
512. 20080275251 Novel Intermediates and Their Use - The invention is directed to novel acyloxy imidazole intermediates useful for making certain C-14 oxycarbonyl 11-06-2008
513. 20080275082 Pharmaceutical Composition - novel pharmaceutical composition comprising the NK 11-06-2008
514. 20080275079 M3 Muscarinic Acetylcholine Receptor Antagonists 11-06-2008
515. 20080275078 Pyrazolo[3,4-B] Pyridine Compounds and Their Use as Pde4 Inhibitors 11-06-2008
516. 20080275040 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders 11-06-2008
517. 20080274148 Microcapsule Composition - The present invention comprises an oral care composition comprising a microcapsule containing a coated water soluble dye 11-06-2008
518. 20080274078 NOVEL USES - generally to the use of human IL-18 combinations in the treatment of cancers 11-06-2008
519. 20080274067 Tooth Whitening Composition - oral care composition comprising an active agent e 11-06-2008
520. 20080269342 Pleuromutilin Derivatives and Its Use - The invention is directed to the L-tartrate salt of trans-3-aminocyclobutyl 10-30-2008
521. 20080269291 Chemical Compounds - The invention is directed to novel indolecarboxamide derivatives 10-30-2008
522. 20080269200 Indole Derivatives and Use Thereof as Kinase Inhibitors in Particular Ikk2 Inhibitors 10-30-2008
523. 20080269197 AROMATIC SULFONES AND THEIR MEDICAL USE - The invention provides compounds of formula : wherein A and B represent the groups - 10-30-2008
524. 20080269195 Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in Medicine 10-30-2008
525. 20080269131 Inhibitors of Akt Activity - Invented are novel 1H-imidazo[4 5-c]pyridin-2-yl compounds the use of such compounds as inhibitors of protein kinase B 10-30-2008
526. 20080269058 Methods of Altering Poppy Characteristics 10-30-2008
527. 20080268044 Novel Process and Formulations - for a novel process of making 6-carboxylic acid derivatives of pyrido[2 10-30-2008
528. 20080262224 Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide 10-23-2008
529. 20080262203 NOVEL COMPOUNDS - antibody which has multiple specificities 10-23-2008
530. 20080262069 CARVEDILOL PHOSPHATE SALTS AND/OR SOLVATES THEREOF, CORRESPONDING COMPOSITIONS, AND/OR METHODS OF TREATMENT 10-23-2008
531. 20080262047 Ppar-Gamma Agonists for Improvement of Cognitive Function in Apoe4 Negative Patients 10-23-2008
532. 20080262040 Chemical Compounds - The invention is directed to novel indazole carboxamide derivatives 10-23-2008
533. 20080262027 Novel Chemical Compounds - This invention relates to newly identified compounds for inhibiting YAK3 proteins and methods for treating diseases 10-23-2008
534. 20080261974 Novel Chemical Compounds - This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases 10-23-2008
535. 20080261945 Compounds Having Activity at Nk3 Receptor and Uses Thereof in Medicine 10-23-2008
536. 20080260781 PROTEOSOME INFLUENZA VACCINE - Improved forms of vaccines which comprise proteosomes and protein antigens are described 10-23-2008
537. 20080260657 Process for Milling Poorly Soluble Drugs in Presence of Liquid Propellants 10-23-2008
538. 20080255359 Novel Chemical Process For the Synthesis of Quinoline Compounds 10-16-2008
539. 20080255358 Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases 10-16-2008
540. 20080255195 Compounds Which Have Activity at M1 Receptor and Their Uses in Medicine 10-16-2008
541. 20080255193 Pharmaceutical Composition - novel pharmaceutical composition comprising the NK 10-16-2008
542. 20080255186 Pyrazolo[3,4-B]Pyridine Compound, and Its Use as a Pde4 Inhibitor 10-16-2008
543. 20080255144 Acylated Piperidines as Glycine Transporter Inhibitors 10-16-2008
544. 20080255143 Inhibitors of Akt Activity - Invented are novel 1H-imidazo[4 5-c]pyridin-2-yl compounds the use of such compounds as inhibitors of protein kinase B 10-16-2008
545. 20080255115 THIAZOLIDINEDIONE DERIVATIVES AS PI3 KINASE INHIBITORS 10-16-2008
546. 20080254087 Methods For Administering Hypoglycemic Agents 10-16-2008
547. 20080254067 Process for the Production of an Influenza Vaccine 10-16-2008
548. 20080249127 Muscarinic Acetylcholine Receptor Antagonists 10-09-2008
549. 20080243100 Absorbent article having fluid transfer layer 10-02-2008
550. 20080242715 Triazolyl Derivatives of Azabicyclo [3.1.0] Hexane as Dopamine D3 Receptor Modulators 10-02-2008
551. 20080242685 Chemical Compounds - The invention is directed to novel azaindole and azaindazole carboxamide derivatives 10-02-2008
552. 20080242667 Pyrimidinyl-Pyrazole Inhibitors of Aurora Kinases 10-02-2008
553. 20080242666 1-6-Substituted (3R,6R)-3-(2,3-Dihydro-1H-Inden-2-Yl)-2,5-Piperazinedione Derivatives as Oxytocin Receptor Antagonists For the Treatment of Preterm Labour, Dysmenorrhea and Endometriosis 10-02-2008
554. 20080234370 Calcilytic Compounds - Novel calcilytic compounds and methods of using them are provided 09-25-2008
555. 20080234315 M3 Muscarinic Acetylcholine Receptor Antagonists 09-25-2008
556. 20080234261 Preparation of 1,6-Disubstituted Azabenzimidazoles as Kinase Inhibitors 09-25-2008
557. 20080234256 Antibacterial Agents - Naphthyridine and related derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are 09-25-2008
558. 20080230298 Method of Applying Oral Compositions - to the temporary and permanent surfaces of the oral cavity comprising the step of obtaining a container and 09-25-2008
559. 20080227858 Inhibitors of matrix metalloproteinase - Compounds of formula : wherein R 09-18-2008
560. 20080227837 Novel Compounds - of formula or a pharmaceutically acceptable salt thereof: wherein G is selected from a group consisting of: phenyl 09-18-2008
561. 20080226719 Combination of Rosiglitazone and Donepezil for Improvement of Cognitive Function 09-18-2008
562. 20080226673 SUBUNIT VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS INFECTION 09-18-2008
563. 20080221185 Glyt1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders 09-11-2008
564. 20080221158 Novel 14 and 15 Membered Ring Compounds - 15-membered macrolides substituted at the 4'' position of formula and pharmaceutically acceptable derivatives 09-11-2008
565. 20080221110 Compounds - Tricyclic nitrogen containing compounds and their use as antibacterials 09-11-2008
566. 20080221108 Anthranilic Acid Derivatives As Hm74A Receptor Agonists 09-11-2008
567. 20080214640 Thrombopoietin mimetics - Invented are non-peptide TPO mimetics 09-04-2008
568. 20080214638 Anthranilic Acid Derivatives Active as the Hm74a Receptor 09-04-2008
569. 20080214623 N-(2,2-Dimethylpropyl)-6- -3-Pyridinecarboxamide 09-04-2008
570. 20080214571 NOVEL COMPOUNDS - method for use of phenyl sulfone compounds of formula in the treatment of anxiety 09-04-2008
571. 20080214549 N-Substituted Glycine Derivatives: Hydroxylase Inhibitors 09-04-2008
572. 20080214455 Novel Chemical Compounds - This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases 09-04-2008
573. 20080213212 Sialoadhesin factor-2 antibodies - Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2 09-04-2008
574. 20080208228 Tongue Cleaning Device Comprising Tongue Cleaning Elements Of Different Materials 08-28-2008
575. 20080206336 Novel Composition Comprising Rosiglitazone and Another Antidiabetic Agent 08-28-2008
576. 20080206189 METHOD OF TREATING CANCER BY ADMINISTERING CONJUGATES COMPRISING HUMAN IL-18 AND SUBSTITUTION MUTANTS THEREOF 08-28-2008
577. 20080200468 2-Substituted 5-Membered Heteroaryl Carboxylates as Hm74a Receptor Agonists 08-21-2008
578. 20080199516 Encapsulation Of Lipid-Based Formulations In Enteric Polymers 08-21-2008
579. 20080199494 VACCINE - formulation for the prevention or amelioration of HIV infection in humans is provided 08-21-2008
580. 20080199490 Immunogenic Composition - The present application discloses an immunogenic composition comprising a Hib saccharide conjugate and at least two further 08-21-2008
581. 20080196437 Apparatus for Shell Freezing a Liquid Content in a Container 08-21-2008